Erratum: Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of experimental & clinical cancer research : CR (2019) 38 1 (474))

Ssu Chuan Lai, Yu Ting Su, Ching Chi Chi, Yung Che Kuo, Kam Fai Lee, Yu Chih Wu, Pei Chi Lan, Muh Hwa Yang, Te Sheng Chang, Yen Hua Huang

研究成果: 雜誌貢獻評論/辯論同行評審

3 引文 斯高帕斯(Scopus)

摘要

In the original publication of this article [1], labelling within Fig. 7a was incorrect. The updated figure is shown below, with 'DMT1' now corrected to read 'DNMT1'.
原文英語
文章編號10
頁數1
期刊Journal of experimental & clinical cancer research : CR
39
發行號1
DOIs
出版狀態已發佈 - 1月 13 2020

ASJC Scopus subject areas

  • 腫瘤科
  • 癌症研究

指紋

深入研究「Erratum: Correction to: DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation (Journal of experimental & clinical cancer research : CR (2019) 38 1 (474))」主題。共同形成了獨特的指紋。

引用此